Drug · DIN 02458047
VENCLEXTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 31, 2016; first marketed October 31, 2016.
- Drug Identification Number (DIN)
- 02458047
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Venetoclax L01XX52
- Class
- Human
- Record last updated
- May 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VENETOCLAX | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 30, 2016: NOC 18536New Drug Submission (NDS)
Other DINs named VENCLEXTA
- DIN 02458039 · Marketed
- DIN 02458055 · Marketed
- DIN 02458063 · Marketed